SOTERA HEALTH COMPANY Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SOTERA HEALTH COMPANY (SHC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.62 million shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-02-27
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 2.19K shares, a 99.92% decline year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was 2.72M shares, a 6066.56% increase year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 28.92K shares, a 660.45% increase year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-06-30 was 15.43K shares, a 10.50% increase year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.62M shares, a 46.84% increase from fiscal 2023.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.10M shares, a 73.56% decline from fiscal 2022.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.16M shares, a 4961.73% increase from fiscal 2021.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 82.21K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2024-12-31 | 1.62M shares 10-K · filed 2025-02-27 | |||
| 2023-12-31 | 2.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 1.10M shares 10-K · filed 2024-02-27 | ||
| 2023-09-30 | 1.10M shares 10-Q · filed 2023-11-01 | |||
| 2022-12-31 | 2.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 2.74M shares derived: sum of 2 quarters · filed 2023-02-28 | 2.76M shares derived: sum of 3 quarters · filed 2023-02-28 | 4.16M shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 28.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 44.35K shares derived: sum of 2 quarters · filed 2022-11-02 | 1.45M shares 10-Q · filed 2022-11-02 | 1.49M shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 15.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.42M shares 10-Q · filed 2022-08-04 | 1.46M shares derived: sum of 3 quarters · filed 2022-08-04 | 1.46M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 1.40M shares 10-Q · filed 2022-05-05 | 1.45M shares derived: sum of 2 quarters · filed 2022-05-05 | 1.45M shares derived: sum of 3 quarters · filed 2022-05-05 | 1.46M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 44.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 47.84K shares derived: sum of 2 quarters · filed 2022-03-01 | 61.80K shares derived: sum of 3 quarters · filed 2022-03-01 | 82.21K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 3.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 17.77K shares derived: sum of 2 quarters · filed 2021-11-10 | 38.18K shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 13.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 34.37K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 20.41K shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |